Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ankaferd Health Products serves as the official distributor for Ankaferd Blood Stopper (ABS) products across the European market. ABS is a unique, standardized herbal hemostatic agent composed of extracts from Vitis vinifera, Glycyrrhiza glabra, Alpinia officinarum, Thymus vulgaris, and Urtica dioica. The product is distinguished by its ability to induce rapid erythrocyte aggregation through the formation of a protein network, providing effective bleeding control regardless of the patient's underlying coagulation status. Ankaferd Health Products provides these solutions in various formats, including ampoules, sprays, and tampons, catering to surgical, dental, and emergency medical applications. The company's mission is to expand the clinical adoption of this innovative botanical hemostat within European healthcare systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Official European distributor of Ankaferd Blood Stopper products.